Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.

@article{Bol2016DendriticCI,
  title={Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.},
  author={Kalijn F. Bol and Gerty Schreibelt and Winald R. Gerritsen and I Jolanda M de Vries and Carl G. Figdor},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2016},
  volume={22 8},
  pages={
          1897-906
        }
}
Dendritic cell (DC) vaccination in cancer patients aims to induce or augment an effective antitumor immune response against tumor antigens and was first explored in a clinical trial in the 1990s. More than two decades later, numerous clinical trials have been performed or are ongoing with a wide variety of DC subsets, culture protocols, and treatment regimens. The safety of DC vaccination and its ability to induce antitumor responses have clearly been established; however, although scattered… CONTINUE READING
Highly Cited
This paper has 70 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 47 extracted citations

Emerging Opportunities and Challenges in Cancer Immunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2016
View 1 Excerpt
Highly Influenced

71 Citations

01020302016201720182019
Citations per Year
Semantic Scholar estimates that this publication has 71 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 102 references

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2016
View 2 Excerpts

Effects of BRAFmutations and BRAF inhibition on immune responses to melanoma

KM Ilieva, I Correa, +3 authors CafferkeyMJ
Mol Cancer Ther 2014;13:2769–83. www.aacrjournals.org Clin Cancer Res; • 2016
View 1 Excerpt

Immunomonitoring tumor-specific T cells in delayed-type CCRFOCUS Clin Cancer Res

IJ deVries, BernsenMR, +3 authors MJ Gerritsen
Clinical Cancer Research 1904 on April • 2016

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2016
View 1 Excerpt

Reversing T-cell Dysfunction and Exhaustion in Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2016
View 1 Excerpt